HANSEATIC MANAGEMENT SERVICES INC - INTERCEPT PHARMACEUTICALS IN ownership

INTERCEPT PHARMACEUTICALS IN's ticker is ICPT and the CUSIP is 45845P108. A total of 186 filers reported holding INTERCEPT PHARMACEUTICALS IN in Q3 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.1%.

Quarter-by-quarter ownership
HANSEATIC MANAGEMENT SERVICES INC ownership history of INTERCEPT PHARMACEUTICALS IN
ValueSharesWeighting
Q1 2023$4
-100.0%
274
+194.6%
0.01%
-18.2%
Q4 2019$12,000
-94.8%
93
-95.5%
0.01%
-95.5%
Q1 2019$232,000
+24.1%
2,077
+12.1%
0.24%
-4.0%
Q4 2018$187,000
-28.4%
1,853
-10.3%
0.25%
+3.7%
Q3 2018$261,0002,0650.24%
Other shareholders
INTERCEPT PHARMACEUTICALS IN shareholders Q3 2018
NameSharesValueWeighting ↓
Carmignac Gestion 2,028,192$229,389,0001.76%
Orbimed Advisors 1,037,000$117,285,0001.33%
BB BIOTECH AG 255,719$28,922,0000.95%
ALTRINSIC GLOBAL ADVISORS LLC 193,369$21,870,0000.74%
FALCON POINT CAPITAL, LLC 44,573$5,041,0000.67%
Rhenman & Partners Asset Management AB 30,000$3,393,0000.54%
INTERNATIONAL BIOTECHNOLOGY TRUST PLC 11,155$1,262,0000.48%
NATIONAL PLANNING CORP 52,400$5,888,0000.44%
HIGHFIELDS CAPITAL MANAGEMENT LP 364,232$41,195,0000.38%
SPHERA FUNDS MANAGEMENT LTD. 15,000$1,697,0000.33%
View complete list of INTERCEPT PHARMACEUTICALS IN shareholders